Zeo ScientifiX, Inc. 8-K
Research Summary
AI-generated summary
Zeo ScientifiX, Inc. Terminates Chief Science Officer (Dr. Kisiday)
What Happened
Zeo ScientifiX, Inc. (ZEOX) filed a Form 8‑K (Item 5.02) on March 27, 2026 announcing that the company terminated the employment of Dr. John D. Kisiday, Ph.D., its Chief Science Officer, effective March 23, 2026.
Key Details
- Position: Chief Science Officer
- Individual: Dr. John D. Kisiday, Ph.D.
- Effective date: March 23, 2026
- Filing: Form 8‑K (Item 5.02) filed March 27, 2026; the filing does not disclose a reason for the termination, severance arrangements, or a named successor.
Why It Matters
Leadership changes in scientific or R&D roles can affect ongoing research programs, development timelines, and partnerships. Investors should monitor future company announcements and SEC filings for information about a replacement, any impacts on R&D activities or timelines, and disclosures about transition or compensation arrangements.
Loading document...